Open an account

Clinuvel Pharmaceuticals

CUVL · ASX

$4.94−$0.09 (−1.79%)TodayMarket closed ·
Prev close $5.03

About CUVL

Clinuvel Pharmaceuticals Ltd. operates as a biopharmaceutical company. The company is focused on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening, acute disorders, as well as healthcare solutions for specialized populations. Its lead therapy, SCENESSE (afamelanotide 16mg), is approved for commercial distribution in Europe, the United States of America, Israel, and Australia as the first systemic photoprotective drug for the prevention of phototoxicity (anaphylactoid reactions and burns) in adult patients with erythropoietic protoporphyria (EPP). The company has operations in Europe, Singapore, and the United States of America. The company develops and manufactures NEURACTHEL (adrenocorticotropic hormone) in different formulations, to target neurological, endocrinological, and degenerative disorders. Its pharmaceutical product, PRENUMBRA, has been developed, and its use is to be expanded in the clinic from stroke to Parkinson's.

Employees
0
Headquarters
Melbourne, Victoria
Listed
Feb 13, 2001
Sector
Health Care
Industry
Biotechnology
Website
clinuvel.com

CUVL key statistics

Market cap
356.94M
Price-earnings ratio
0.00
Dividend yield
0.70%
Average volume
6.60K
Volume
4.71K
Open price
$5.00
High today
$5.02
Low today
$4.93
52 Week high
$8.92
52 Week low
$4.91

Clinuvel Pharmaceuticals (CUVL) at a glance

As of Oct 23, 2026, Clinuvel Pharmaceuticals (CUVL) shares are priced at $4.94, giving the company a market cap of 356.94M, a price-to-earnings ratio of 0.00 and a dividend yield of 0.70%.

Today the stock has traded between $4.93 and $5.02. The current price is 0.2% above the day's low and 1.6% below its high.

Volume so far is 4.71K shares, below the average of 6.60K shares a day.

Over the past year Clinuvel Pharmaceuticals has ranged from $4.91 to $8.92, and now sits 1% of the way up that range.

CUVL news

  • 12 Health Care Stocks Moving In Thursday's Intraday Session

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.